Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement
Retrieved on:
Thursday, June 9, 2022
Professional Services, Health, Finance, Clinical Trials, Pharmaceutical, Biotechnology, NYU Langone Health, Power Spikes II, Neuroscience, Business architecture, Tilray, Forward-looking statement, CEO, Silver, Combination, Cannabis, U.S. Securities and Exchange Commission, Neurology, Acquisition, NASDAQ, Psychiatry, Pharmaceutical industry, Risk management, Medicine
Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (Silver Spike II or SPKB) (NASDAQ: SPKB/SPKBU/SPKBW), a publicly traded special purpose acquisition company (SPAC), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger (the Business Combination Agreement), effective immediately, as a result of current unfavorable market conditions.
Key Points:
- Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (Silver Spike II or SPKB) (NASDAQ: SPKB/SPKBU/SPKBW), a publicly traded special purpose acquisition company (SPAC), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger (the Business Combination Agreement), effective immediately, as a result of current unfavorable market conditions.
- Silver Spike II intends to continue in its efforts to identify a prospective target business for an initial business combination.
- About Silver Spike Acquisition Corp. II
Silver Spike Acquisition Corp. II, an affiliate of Silver Spike Capital, is a blank check company focused on the cannabis and alternative health and wellness industries, formed for the purpose of effecting a merger, amalgamation, share exchange, share purchase, reorganization, or similar business combination with one or more businesses. - This document contains certain forward-looking statements within the meaning of the federal securities laws, including with respect to the pursuit by Silver Spike Acquisition Corp. II (Silver Spike II) of a business combination transaction.